Healthcare provider profile · identity verified

Leonidas Vlantis

Family Practice · FLUSHING, NY · NPI 1073008132

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	877	275
Amlodipine Besylate	Amlodipine Besylate	704	216
Levothyroxine Sodium	Levothyroxine Sodium	517	144
Losartan Potassium	Losartan Potassium	410	114
Metformin Hcl	Metformin Hcl	350	102
Metoprolol Succinate	Metoprolol Succinate	327	98
Pantoprazole Sodium	Pantoprazole Sodium	317	121
Simvastatin	Simvastatin	314	89
Rosuvastatin Calcium	Rosuvastatin Calcium	302	92
Omeprazole	Omeprazole	236	71
Tamsulosin Hcl	Tamsulosin Hcl	178	64
Furosemide	Furosemide	158	56
Hydrochlorothiazide	Hydrochlorothiazide	152	47
Meloxicam	Meloxicam	152	67
Alprazolam	Alprazolam	151	45
Lisinopril	Lisinopril	150	43
Albuterol Sulfate Hfa	Albuterol Sulfate	136	50
Escitalopram Oxalate	Escitalopram Oxalate	136	50
Atenolol	Atenolol	134	40
Azithromycin	Azithromycin	133	110
Sertraline Hcl	Sertraline Hcl	126	40
Gabapentin	Gabapentin	125	49
Fluticasone Propionate	Fluticasone Propionate	123	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	110	35
Allopurinol	Allopurinol	108	33
Alendronate Sodium	Alendronate Sodium	105	38
Enalapril Maleate	Enalapril Maleate	104	32
Finasteride	Finasteride	103	30
Famotidine	Famotidine	93	35
Vitamin D2	Ergocalciferol (Vitamin D2)	92	34
Eliquis	Apixaban	91	25
Jardiance	Empagliflozin	91	21
Zolpidem Tartrate	Zolpidem Tartrate	91	23
Clopidogrel	Clopidogrel Bisulfate	89	28
Carvedilol	Carvedilol	85	26
Irbesartan	Irbesartan	84	21
Trazodone Hcl	Trazodone Hcl	84	24
Duloxetine Hcl	Duloxetine Hcl	83	19
Valsartan	Valsartan	78	21
Pravastatin Sodium	Pravastatin Sodium	77	22
Januvia	Sitagliptin Phosphate	76	22
Potassium Chloride	Potassium Chloride	75	25
Glimepiride	Glimepiride	71	17
Prednisone	Prednisone	71	57
Metoprolol Tartrate	Metoprolol Tartrate	70	25
Ozempic	Semaglutide	70	19
Montelukast Sodium	Montelukast Sodium	69	19
Oxycodone Hcl	Oxycodone Hcl	68	suppressed
Glipizide Er	Glipizide	66	20
Synthroid	Levothyroxine Sodium	66	20
Donepezil Hcl	Donepezil Hcl	60	22
Ramipril	Ramipril	60	17
Ezetimibe	Ezetimibe	58	19
Clonazepam	Clonazepam	57	14
Metformin Hcl Er	Metformin Hcl	54	17
Diclofenac Sodium	Diclofenac Sodium	51	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	42
Xarelto	Rivaroxaban	49	12
Lorazepam	Lorazepam	48	15
Ketoconazole	Ketoconazole	43	19
Meclizine Hcl	Meclizine Hcl	43	25
Triamcinolone Acetonide	Triamcinolone Acetonide	43	26
Citalopram Hbr	Citalopram Hydrobromide	40	14
Trulicity	Dulaglutide	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	37	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	31
Olmesartan Medoxomil	Olmesartan Medoxomil	37	13
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	34	suppressed
Spironolactone	Spironolactone	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Fenofibrate	Fenofibrate,micronized	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	27
Farxiga	Dapagliflozin Propanediol	29	suppressed
Hydrocortisone	Hydrocortisone	29	11
Folic Acid	Folic Acid	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Ammonium Lactate	Ammonium Lactate	27	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	13
Cefuroxime	Cefuroxime Axetil	26	23
Lovastatin	Lovastatin	26	11
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Naproxen	Naproxen	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Metronidazole	Metronidazole	24	14
Nifedipine Er	Nifedipine	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Mupirocin	Mupirocin	22	15
Labetalol Hcl	Labetalol Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	15
Methylprednisolone	Methylprednisolone	20	19
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Nystatin	Nystatin	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	18	13
Diazepam	Diazepam	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Telmisartan	Telmisartan	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	15
Belsomra	Suvorexant	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Invokana	Canagliflozin	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Terconazole	Terconazole	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Repaglinide	Repaglinide	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Cephalexin	Cephalexin	13	12
Colchicine	Colchicine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glipizide Xl	Glipizide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Primidone	Primidone	11	suppressed
Prolia	Denosumab	11	suppressed
Risperidone	Risperidone	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error